MICHELLE DIXON: Open Payments
NPI 1760972079 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 9 payments from 7 companies in 2025. Trend: 2023 $45 · 2024 $157 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $32 |
| Indivior Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Abbott Laboratories | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
Products named: SUBLOCADE, AIRSUPRA, Rybelsus, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, JARDIANCE, Ozempic, GIVLAARI.
Industry payments across MD — which companies pay providers there.
